- Home
- ANVS vs FEIM Comparison
ANVS vs FEIM Comparison
Compare ANVS & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- FEIM
- Stock Information
- Founded
- ANVS 2008
- FEIM 1961
- Country
- ANVS United States
- FEIM United States
- Employees
- ANVS N/A
- FEIM N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- FEIM Electrical Products
- Sector
- ANVS Health Care
- FEIM Industrials
- Exchange
- ANVS Nasdaq
- FEIM Nasdaq
- Market Cap
- ANVS 44.6M
- FEIM 224.9M
- IPO Year
- ANVS 2020
- FEIM N/A
- Fundamental
- Price
- ANVS $2.75
- FEIM $19.60
- Analyst Decision
- ANVS Strong Buy
- FEIM
- Analyst Count
- ANVS 4
- FEIM 0
- Target Price
- ANVS $18.00
- FEIM N/A
- AVG Volume (30 Days)
- ANVS 437.3K
- FEIM 420.7K
- Earning Date
- ANVS 08-14-2025
- FEIM 07-10-2025
- Dividend Yield
- ANVS N/A
- FEIM 5.09%
- EPS Growth
- ANVS N/A
- FEIM 319.88
- EPS
- ANVS N/A
- FEIM 2.48
- Revenue
- ANVS N/A
- FEIM $69,811,000.00
- Revenue This Year
- ANVS N/A
- FEIM N/A
- Revenue Next Year
- ANVS N/A
- FEIM N/A
- P/E Ratio
- ANVS N/A
- FEIM $7.93
- Revenue Growth
- ANVS N/A
- FEIM 26.30
- 52 Week Low
- ANVS $1.11
- FEIM $8.83
- 52 Week High
- ANVS $14.80
- FEIM $24.77
- Technical
- Relative Strength Index (RSI)
- ANVS 57.81
- FEIM 44.10
- Support Level
- ANVS $2.24
- FEIM $20.42
- Resistance Level
- ANVS $2.97
- FEIM $23.47
- Average True Range (ATR)
- ANVS 0.26
- FEIM 1.43
- MACD
- ANVS 0.02
- FEIM -0.23
- Stochastic Oscillator
- ANVS 65.58
- FEIM 15.43
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.